keyword :
分类
Products
  • Name: Ciprofloxacin Hydrochloride Ear Drops(10ml)
  • Add time: 2015-05-15
  • Views : 76

[Drug Name]
Generic Name:盐酸环丙沙星滴耳液
English name:Ciprofloxacin Hydrochloride Ear Drops
Pinyin:Yansuan Huanbingshaxing Di'erye
Ingredient
Chemical name: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl) -3-quinolinecarboxylic acid hydrochloride monohydrate.
Chemical Structure:
Formula: C17H18FN3O3 • HCl • H2O
Molecular Weight: 385.82
[Character]
This product is light yellow clear or viscous liquid.
Indications
For the following infections caused by susceptible strains of: otitis media, otitis externa, myringitis, mastoid cavity postoperative infection.
[Specification]

(1) 10ml: 30mg (by C17H18FN3O3 dollars);
(2) 5ml: 15mg (by C17H18FN3O3 dollars).
Dosage
An adult from 6 to 10 drops 2 or 3 times a day. Post-dot ear ears bath for about 10 minutes, the number of points ear appropriate changes according to the symptoms of children with appropriate reduction in the number of drops.
[Adverse reactions]
Occasionally in earache and itching.
Taboo
Disabled patients of the goods and quinolones allergies.
Precautions
1. Only for point ear.
2. The product is generally applicable to limitations in the middle ear mucosal sites otitis topical treatment. If the inflammation has been around a diffuse and tympanum when, in addition to local treatment, should also be given oral agents such as systemic therapy.
3. If using this medicine temperature is too low, it may cause dizziness. Therefore, the temperature should be close to body temperature.
4. The allergy symptoms should be discontinued immediately.
5. using this medication is limited to four weeks. If continuous administration, it should be used with caution.
[Pregnant women and lactating women drug]
Animal experiments have not yet confirmed the quinolones have teratogenic effects, but doing research on pregnant women use no clear conclusion. Given the drug can cause minor animals joint disease, so pregnant women, lactating women should be used with caution.
Pediatric Use
This product is generally not used for infants.
[Geriatric medicine]
Not to proceed with the experiment and no reliable references.
Drug interactions
Long-term heavy use of topically absorbed, may produce systemic medication the same drug interactions, as can increase the plasma concentration of theophylline, cyclosporine, probenecid and other drugs, and enhance the anticoagulant effect of warfarin , metabolic disturbances such as caffeine.
Overdosage
Not to proceed with the experiment and no reliable references.
Pharmacology and Toxicology
This product is a broad-spectrum antimicrobial effect, especially in high aerobic gram-negative bacilli antimicrobial activity against these bacteria with good antibacterial effect in vitro: the majority of Enterobacteriaceae bacteria, including Bacillus citrate, sewer, gas cloacae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia bacteria. Of multi-resistant bacteria often also have antibacterial activity. Penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella enzyme species have high antibacterial activity. Most strains of Pseudomonas aeruginosa and other antibacterial effect. The product of methicillin-sensitive Staphylococcus aureus antibacterial activity against Streptococcus pneumoniae, hemolytic streptococcus and Enterococcus faecalis having only moderate antibacterial activity. Chlamydia trachomatis, Mycoplasma, Legionella also a good effect on Mycobacterium tuberculosis and atypical mycobacteria have antibacterial activity. The antibacterial activity of anaerobic difference.
Ciprofloxacin as fungicides, by acting on bacterial DNA gyrase A subunit, inhibit DNA synthesis and replication leading to bacterial death.
Pharmacokinetics
This product is topical, and only a small amount of absorption.
[Storage]
Shading, sealed.
[Packaging]
Plastic bottles, bottle 10ml; carton packaging, 1 bottle / box.
Plastic bottles, bottle 5ml; carton packaging, 1 bottle / box.
[Validity]
24 months
[Executive standard]
State Food and Drug Administration National Drug Standards WS1- (X-020) -2005Z-2013
Approval Number
Zhunzi H10950352
Manufacturer
Company Name: Shenyang Hongqi Pharmaceutical Co., Ltd.
Production Address: Shenyang Hunnan New District envelope 6th Street
Postal Code: 110179
Telephone number (024) 2,378,626,023,786,261
Fax: (024) 23786263

 

The above is for reference
If you have questions can contact the manufacturer